Rock Springs Capital Management LP Kymera Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $1.47 Billion
- Q2 2025
A detailed history of Rock Springs Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 450,374 shares of KYMR stock, worth $21.3 Million. This represents 1.33% of its overall portfolio holdings.
Number of Shares
450,374
Previous 794,437
43.31%
Holding current value
$21.3 Million
Previous $21.7 Million
9.61%
% of portfolio
1.33%
Previous 1.3%
Shares
19 transactions
Others Institutions Holding KYMR
# of Institutions
217Shares Held
72.2MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$324 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$314 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$310 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$266 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$260 Million9.44% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.59B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...